Case | Nosocomial (Yes/No) | Agea (years) | Sex (M/F) | Underlying Disease | RSV infection | WBCb (per microliter) | RSV Treatment, Duration (days) | Additional antibiotic treatment | Oxygen (Yes/No) | RSV-related outcome | Virus shedding (days) |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | yes | 16 | M | Acute myeloid leukemia (recurrent) | LRTI | 0 | oral Ribavirin, 64 | Yes | Yes | Remission | At least 63 |
2 | yes | 15 | M | Severe aplastic anemia | LRTI | 800 | oral Ribavirin, 10 | Yes | Yes | Remission | 7 |
3 | Yes | 16 | M | Acute lymphoid leukemia | URTI | 1200 | - | Yes | Yes (at night) | Remission | At least 6 |
4c | Yes | 9 | M | Post-transplant Burkitt's leukemia | URTI | 300 | - | Yes | Yes | Remission | 17d |
5 | Yes | 1 | F | Neuroblastoma | URTI | 9500 | intravenous Ribavirin, 8 | Yes | Yes | Remission | 44 |
6 | Possible | 3 | F | Ewing Sarcoma | URTI | 500 | - | Yes | Yes | Remission | 5 |
7 | Yes | 10 | F | Acute lymphoid leukemia | URTI | 700 | - | Yes | No | Remission | 4 |
8 | Possible | 14 | F | Acute lymphoid leukemia | URTI | 290 | oral Ribavirin, 8 | Yes | No | Remission | 13 |